Albuquerque, United States
BennuBio, Inc., founded in 2018, is a U.S.-based biotechnology company revolutionizing cell analysis systems. Positioned at the intersection of Biotechnology and Health Care, the company is pioneering technologies that significantly enhance both single and multi-cellular analysis.
Their flagship product, VelocytTM, accommodates high-volume flow rates, facilitating refined analysis and enriched cell recovery for various applications. This innovation is particularly notable in its approach to immuno-oncology treatments and high-precision diagnostics, although it currently lacks US FDA approval for in vitro diagnostic use.
BennuBio's recent engagement with BioTools Innovator through a Non Equity Assistance investment dated 06 June 2023 highlights the industry's recognition of its potential. This support might catalyze further advancements and possible regulatory approvals, inviting investors to explore the promising future prospects of this cutting-edge biotech venture.
